Download PDF
CC BY-NC-ND 4.0 · Planta Medica International Open 2017; 4(01): e8-e16
DOI: 10.1055/s-0043-107030
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Morinda citrifolia Leaf Extract Suppressed Metastasised Cancer Progression via EGFR and MAPK Pathways

Swee-Ling Lim
1   UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor, Malaysia
,
Noordin M. Mustapha
2   Faculty of Veterinary Medicine, Universiti Putra Malaysia, Serdang, Selangor, Malaysia
,
Yong-Meng Goh
2   Faculty of Veterinary Medicine, Universiti Putra Malaysia, Serdang, Selangor, Malaysia
,
Heshu S. Rahman
1   UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor, Malaysia
,
Suhaila Mohamed
1   UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor, Malaysia
› Author Affiliations
Further Information

Publication History

received 12 September 2016
revised 20 March 2017

accepted 21 March 2017

Publication Date:
23 May 2017 (online)

   Permissions and Reprints

Abstract

Morinda citrifolia leaf has anti-inflammatory and immune enhancing effects against lung cancer. The effects of the extract on metastasised lung and liver cancer tissues were compared to Erlotinib (an anticancer drug) for cancer aggression, proliferation, and angiogenesis. Forty Balb/c mice were induced to develop metastatic lung and liver tumours via xenograft subcutaneous injection of non-small cell lung cancer A549 cells (2×107 cells/mouse) into their backs. The extract (150 and 300 mg/kg body weight) and Erlotinib (50 mg/kg body weight) were fed to the mice for 21 days, and the microstructure and mRNA expressions of the tumour tissues were analysed. The extract dose-dependently downregulated RAC-alpha serine/threonine-protein kinase, B cell leukaemia/lymphoma 2, mitogen-activated protein kinase kinase kinase 14, mitogen-activated protein kinase 1, and vascular endothelial growth factor alpha in these tissues. The scopoletin (coumarin) and epicatechin (flavonoid) standardised extract also mitigated the cancerous tissues microstructure changes, and suppressed the tissue remodeling enzyme (matrix metallopeptidase 9) and angiogenesis biomarkers (epidermal growth factor receptor and integrin). The 300 mg extract/kg body weight was more effective than the 50 mg Erlotinib/kg body weight in suppressing the lung and liver tumoor metastasis. The extract inhibited the cancer aggression by interfering with epidermal growth factor receptor and mitogen-activated protein kinase carcinogenesis pathways, and suppressing proliferation, tissue remodelling, and angiogenesis without any observable side effects at the given dose.

Key words

Morinda citrifolia - Rubiaceae - scopoletin - epicatechin - carcinogenesis - angiogenesis

Supporting Information

    1H NMR spectra of tomentin, HPLC and LC-MS profiles of the extract standardised to scopoletin and epicatechin and a listing of bioactive chemical contents of M. citrifolia leaf are available online at http://www.thieme-connect.de/products.
  • Supporting Information
 

  • References

  • 1 Ramalingam S, Sandler AB. Salvage therapy for advanced non-small cell lung cancer: Factors influencing treatment selection. Oncologist 2006; 11: 655-665
    CrossrefPubMedGoogle Scholar
  • 2 Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S, Campos D, Maoleekoonpiroj S, Smylie M, Martins R, van Kooten M, Dediu M, Findlay B, Tu D, Johnston D, Bezjak A, Clark G, Santabárbara P, Seymour L. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005; 353: 123-132
    CrossrefPubMedGoogle Scholar
  • 3 Politi K, Fan P, Shen R, Zakowski M, Varmus H. Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma. Dis Model Mech 2010; 3: 111-119
    CrossrefPubMedGoogle Scholar
  • 4 Deng S, West B, Jensen C. A quantitative comparison of phytochemical components in global noni fruits and their commercial products. Food Chem 2010; 122: 267-270
    CrossrefPubMedGoogle Scholar
  • 5 Lim SL, Goh YM, Noordin MM, Rahman HS, Othman HH, Abu Bakar NA, Mohamed S. Morinda citrifolia edible leaf extract enhanced immune response against lung cancer. Food Funct 2016; 7: 741-751
    CrossrefPubMedGoogle Scholar
  • 6 West B, Tani H, Palu A, Tolson C, Jensen C. Safety tests and antinutrient analyses of noni (Morinda citrifolia L.) leaf. J Sci Food Agric 2007; 87: 2583-2588
    CrossrefPubMedGoogle Scholar
  • 7 Lagarto A, Bueno V, Merino N, Piloto J, Valdes O, Aparicio G, Bellma A, Couret M, Vega Y. Safety evaluation of Morinda citrifolia (noni) leaves extract: assessment of genotoxicity, oral short term and subchronic toxicity. J Intercult Ethnopharmacol 2013; 2: 15-22
    CrossrefPubMedGoogle Scholar
  • 8 Nayak S, Mengi S. Immunostimulant activity of the extracts and bioactives of the fruits of Morinda citrifolia. Pharm Biol 2009; 47: 248-254
    CrossrefPubMedGoogle Scholar
  • 9 West B, Deng S, Palu A. Antioxidant and toxicity tests of roasted noni (Morinda citrifolia) leaf infusion. Int J Food Sci Technol 2009; 44: 2142-2146
    CrossrefPubMedGoogle Scholar
  • 10 Dussossoy E, Brat P, Bony E, Boudard F, Poucheret P, Mertz C, Giaimis J, Michel A. Characterization, anti-oxidative and anti-inflammatory effects of Costa Rican noni juice (Morinda citrifolia L.). J Ethnopharmacol 2011; 133: 108-115
    CrossrefPubMedGoogle Scholar
  • 11 Leinonen T, Pirinen R, Böhm J, Johansson R, Ropponen K, Kosma VM. Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, β-catenin and prognosis. Lung Cancer 2006; 51: 313-321
    CrossrefPubMedGoogle Scholar
  • 12 Mahller YY, Vaikunth SS, Currier MA, Miller SJ, Ripberger MC, Hsu YH, Mehrian-Shai R, Collins MH, Crombleholme TM, Ratner N, Cripe TP. Oncolytic HSV and erlotinib inhibit tumor growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft model. Mol Ther 2007; 15: 279-286
    CrossrefPubMedGoogle Scholar
  • 13 Cai X, Yang J, Zhou J, Lu W, Hu C, Gu Z, Huo J, Wang X, Cao P. Synthesis and biological evaluation of scopoletin derivatives. Bioorg Med Chem 2013; 21: 84-92
    CrossrefPubMedGoogle Scholar
  • 14 Liu XL, Zhang L, Fu XL, Chen K, Qian BC. Effect of scopoletin on PC3 cell proliferation and apoptosis. Acta Pharmacol Sin 2001; 22: 929-933
    PubMedGoogle Scholar
  • 15 Kim EK, Kwon KB, Shin BC, Seo EA, Lee YR, Kim JS, Park JW, Park BH, Ryu DG. Scopoletin induces apoptosis in human promyeloleukemic cells, accompanied by activations of nuclear factor κB and caspase-3. Life Sci 2005; 77: 824-836
    CrossrefPubMedGoogle Scholar
  • 16 Kim D, Mollah ML, Kim K. Induction of apoptosis of SW480 human colon cancer cells by (-)-epicatechin isolated from Bulnesia sarmienti. Anticancer Res 2012; 32: 5353-5361
    PubMedGoogle Scholar
  • 17 Manuele MG, Ferraro G, Arcos ML, López P, Cremaschi G, Anesini C. Comparative immunomodulatory effect of scopoletin on tumoral and normal lymphocytes. Life Sci 2006; 79: 2043-2048
    CrossrefPubMedGoogle Scholar
  • 18 Saha A, Kuzuhara T, Echigo N, Suganuma M, Fujiki H. New role of (-)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin. Cancer Prev Res 2010; 3: 953-962
    CrossrefPubMedGoogle Scholar
  • 19 Ravindranath MH, Saravanan TS, Monteclaro CC, Presser N, Ye X, Selvan SR, Brosman S. Epicatechins purified from green tea (Camellia sinensis) differentially suppress growth of gender-dependent human cancer cell lines. Evid Based Complement Alternat Med 2006; 3: 237-247
    CrossrefPubMedGoogle Scholar
  • 20 Hodkinson PS, Elliott T, Wong WS, Rintoul RC, Mackinnon AC, Haslett C, Sethi T. ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinase. Cell Death Differ 2006; 13: 1776-1788
    CrossrefPubMedGoogle Scholar
  • 21 Kim S, Rabbani ZN, Dewhirst MW, Vujaskovic Z, Vollmer RT, Schreiber EG, Oosterwijk E, Kelley MJ. Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer 2005; 49: 325-335
    CrossrefPubMedGoogle Scholar
  • 22 Siefert SA, Sarkar R. Matrix metalloproteinases in vascular physiology and disease. Vascular 2012; 20: 210-216
    CrossrefPubMedGoogle Scholar
  • 23 Montague R, Hart CA, George NJ, Ramani VA, Brown MD, Clarke NW. Differential inhibition of invasion and proliferation by bisphosphonates: anti-metastatic potential of Zoledronic acid in prostate cancer. Eur Urol 2004; 46: 389-402
    CrossrefPubMedGoogle Scholar
  • 24 Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL, Lin JP, Ma YS, Wu CC, Chung JG. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor (VEGF). Cancer Lett 2009; 285: 127-133
    CrossrefPubMedGoogle Scholar
  • 25 Karl E, Warner K, Zeitlin B, Kaneko T, Wurtzel L, Jin T, Chang J, Wang S, Wang CY, Strieter RM, Nunez G, Polverini PJ, Nör JE. Bcl-2 Acts in a proangiogenic signaling pathway through nuclear factor-κB and CXC chemokines. Cancer Res 2005; 65: 5063-5069
    CrossrefPubMedGoogle Scholar
  • 26 Huang Q, Sheibani N. High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs. Am J Physiol Physiol 2008; 295: C1647-C1657
    PubMedGoogle Scholar
  • 27 Emerling BM, Weinberg F, Liu JL, Mak TW, Chandel NS. PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a). PNAS 2008; 105: 2622-2627
    CrossrefPubMedGoogle Scholar
  • 28 Lawson MH, Cummings NM, Rassl DM, Vowler SL, Wickens M, Howat WJ, Brenton JD, Murphy G, Rintoul RC. Bcl-2 and β1-integrin predict survival in a tissue microarray of small cell lung cancer. Br J Cancer 2010; 103: 1710-1715
    CrossrefPubMedGoogle Scholar
  • 29 Klein S, de Fougerolles AR, Blaikie P, Khan L, Pepe A, Green CD, Koteliansky V, Giancotti FG. α5β1 Integrin activates an NF-κB-dependent program of gene expression important for angiogenesis and inflammation. Mol Cell Biol 2002; 22: 5912-5922
    CrossrefPubMedGoogle Scholar
  • 30 Carbonell WS, DeLay M, Jahangiri A, Park CC, Aghi MK. β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma. Cancer Res 2013; 73: 3145-3154
    CrossrefPubMedGoogle Scholar
  • 31 Lim SL, Mustapha NM, Goh YM, Bakar NA, Mohamed S. Metastasized lung cancer suppression by Morinda citrifolia (Noni) leaf compared to Erlotinib via anti-inflammatory, endogenous antioxidant responses and apoptotic gene activation. Mol Cell Biochem 2016; 416: 85-97
    CrossrefPubMedGoogle Scholar
  • 32 Lu ZJ, Song QF, Jiang SS, Song Q, Wang W, Zhang GH, Kan B, Chen LJ, Yang JL, Luo F, Qian ZY, Wei YQ, Gou LT. Identification of ATP synthase beta subunit (ATPB) on the cell surface as a non-small cell lung cancer (NSCLC) associated antigen. BMC Cancer 2009; 9: 16
    CrossrefPubMedGoogle Scholar